"La Clinique de Maisons-Laffitte est un établissement de santé pluridisciplinaire situé à Maisons-Laffitte, en Ile-de-France. Elle fait partie du Groupe Vivalto Santé, troisième acteur national de l'hospitalisation privée."

During the past decade, Hopital Des Courses conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital Des Courses" are "Chemotherapy-induced Anemia" (1 trials), "Chemotherapy-induced Febrile Neutropenia (FN)" (1 trials), "Malignant Hemopathy" (1 trials) and "Solid Tumors" (1 trials). Many other conditions were trialed in "Hopital Des Courses" in a lesser frequency.

Most popular intervention types in "Hopital Des Courses" are "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nivestim®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Des Courses" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Des Courses". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hopital Des Courses, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Des Courses, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".